CTOs on the Move

Specific Diagnostics

www.specific.com

 
Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Pro 2 Respiratory Services

Pro 2 Respiratory Services is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pedigo Products Inc

Pedigo is the premier manufacturer of stainless steel and chrome equipment for the healthcare industry. With over 60 years of experience in manufacturing and healthcare equipment sales, we have innovated a number of products and concepts that bring

Lifeline of Ohio

Lifeline of Ohio is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Dental Partners, Inc.

American Dental Partners, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Accelerate Diagnostics

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The companys revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the Accelerate ID/AST System development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.